Microbot MedicalMBOT +1.07%21 EV-to-FCF is -3.62 as of Jul. 12, 2026. GuruFocus rates MBOT with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Microbot Medical ranks worse than 240384.38% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Microbot Medical's Enterprise Value is $55.68 Mil.
Microbot Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-15.38 Mil. Therefore, Microbot Medical's EV-to-FCF for today is -3.62.
The historical rank and industry rank for Microbot Medical's EV-to-FCF or its related term are showing as below:
MBOT'
s EV-to-FCF Range Over the Past 10 Years
Min: -6.65 Med: 0.03 Max: 1.03
Current: -3.62
During the past 13 years, the highest EV-to-FCF of Microbot Medical was 1.03. The lowest was -6.65. And the median was 0.03.
MBOT's EV-to-FCF is ranked worse than 100% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs MBOT: -3.62
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Microbot Medical's PE Ratio (TTM) for today is calculated as:
Microbot Medical's share price for today is $1.895.
Microbot Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Microbot Medical EV-to-FCF Related Terms
Microbot Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Microbot Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Microbot Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Microbot Medical's EV-to-FCF falls into.
Microbot Medical's current Enterprise Value is $55.68 Mil.
Microbot Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbot Medical (MBOT) has a EV-to-FCF of -3.62 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Microbot Medical and its competitors. According to the industry distribution chart, Microbot Medical ranks #999999 out of 416 companies in the Medical Devices & Instruments industry.
Is Microbot Medical's EV-to-FCF too high?
Microbot Medical's current EV-to-FCF is -3.62. Based on the distribution chart, Microbot Medical ranks #999999 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Microbot Medical has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's EV-to-FCF compare to STXS and POCI?
According to the Medical Devices & Instruments industry distribution chart, Microbot Medical ranks #999999 out of 416 companies for EV-to-FCF. This places Microbot Medical in the lower half of its industry. The industry median EV-to-FCF is 23.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Microbot Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbot Medical's current EV-to-FCF is -3.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (MBOT) has a current EV-to-FCF of -3.62. The current EV-to-FCF is -3.62. Microbot Medical's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Microbot Medical (MBOT), the current EV-to-FCF is -3.62 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
21GF Score
Get the complete analysis for MBOT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MBOT has been successfully added to your 
